| scholarly article | Q13442814 |
| P356 | DOI | 10.7326/0003-4819-123-10-199511150-00002 |
| P698 | PubMed publication ID | 7574192 |
| P2093 | author name string | Calori G | |
| D'Angelo A | |||
| Mazzola G | |||
| Fermo I | |||
| Paroni R | |||
| Vigano' D'Angelo S | |||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | patient | Q181600 |
| P1104 | number of pages | 7 | |
| P304 | page(s) | 747-753 | |
| P577 | publication date | 1995-11-01 | |
| P1433 | published in | Annals of Internal Medicine | Q564416 |
| P1476 | title | Prevalence of moderate hyperhomocysteinemia in patients with early-onset venous and arterial occlusive disease. | |
| P478 | volume | 123 |
| Q44576908 | A 2-step strategy to reduce the need for methionine-loading tests to diagnose hyperhomocysteinemia |
| Q44570556 | A common mutation C677T in the 5,10-methyltetrahydrofolate reductase gene is associated to idiopathic deep venous thrombosis |
| Q36018473 | A preliminary study of inherited thrombophilic risk factors in different clinical manifestations of venous thromboembolism in central Iran |
| Q44514117 | ACE DD genotype: an independent predisposition factor to venous thromboembolism |
| Q45880926 | Absence of hyperhomocysteinemia in ten patients with primary pulmonary hypertension |
| Q38500772 | Aetiological diagnosis of middle-aged and elderly cryptogenic ischaemic cerebral vascular disease |
| Q44930530 | Atherosclerosis and folic acid supplementation trial in chronic renal failure: baseline results |
| Q34108806 | Atherosclerosis and systemic lupus erythematosus |
| Q57267273 | C677T (thermolabile alanine/valine) polymorphism in methylenetetrahydrofolate reductase (MTHFR): its frequency and impact on plasma homocysteine concentration in different European populations |
| Q73378405 | C677T mutation in the methylene tetrahydrofolate reductase gene as a risk factor for venous thrombotic disease in Austrian patients |
| Q34196159 | Clinical evaluation of hypercoagulable states |
| Q51564032 | Combination of low-dose folic acid and pyridoxine for treatment of hyperhomocysteinaemia in patients with premature arterial disease and their relatives. |
| Q50215087 | Comparative effects of acute-methionine loading on the plasma sulfur-amino acids in NAC-supplemented HIV+ patients and healthy controls. |
| Q44909917 | Detection of 677CT/1298AC "double variant" chromosomes: implications for interpretation of MTHFR genotyping results |
| Q34109461 | Diagnosis and treatment of hyperhomocysteinemia |
| Q35112558 | Effect of Platelet Glycoprotein IIb/IIIa PLA2 Polymorphism on Severity of Pulmonary Thromboembolism |
| Q44114514 | Effect of enoxaparin on homocysteine concentration in warfarin-treated patients |
| Q42587189 | Elevated total plasma homocysteine and 677C-->T mutation of the 5,10-methylenetetrahydrofolate reductase gene in thrombotic vascular disease |
| Q43929509 | Evolution of homocysteine during ovarian stimulation for IVF or ICSI |
| Q58320513 | Fatal haemorrhagic infarct in an infant with homocystinuria |
| Q36030472 | Gene-gene and gene-environment interactions in mild hyperhomocysteinemia. |
| Q41245762 | General internal medicine update. Information clinicians and teachers need to know |
| Q82459935 | Genetic Mutations in Turkish Population With Pulmonary Embolism and Deep Venous Thrombosis |
| Q50957387 | Genetic prothrombotic mutations are common in neonates but are not associated with umbilical catheter-associated thrombosis. |
| Q22306331 | Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association |
| Q46908421 | Hereditary thrombophilia in ethnic Omani patients |
| Q79844617 | Heterozygous methylene tetrahydrofolate reductase mutation with mild hyperhomocysteinemia associated with deep vein thrombosis |
| Q77898326 | High-performance liquid chromatographic determination of total plasma homocysteine with or without internal standards |
| Q44032750 | Homocysteine and vascular access thrombosis in hemodialysis patients |
| Q46877580 | Homocysteine in assisted reproduction: does oestradiol influence homocysteine levels? |
| Q38223130 | Homocysteine in renovascular complications: hydrogen sulfide is a modulator and plausible anaerobic ATP generator |
| Q31574546 | Homocysteine inhibits inactivation of factor Va by activated protein C. |
| Q78200195 | Homocysteine metabolism in cardiovascular cells and tissues: implications for hyperhomocysteinemia and cardiovascular disease |
| Q45237818 | Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies. |
| Q33732664 | Homocysteine. |
| Q74455822 | Homocysteinemia and livedoid vasculitis |
| Q50521374 | Homocystinuria: a cause of hypercoagulability that may be unrecognized. |
| Q34435609 | Hyperhomocysteinaemia and associated disease |
| Q51200551 | Hyperhomocysteinaemia and vascular access thrombosis among chronic hemodialysis patients in Taiwan: a retrospective study. |
| Q74578253 | Hyperhomocysteinaemia and vascular disease |
| Q37256090 | Hyperhomocysteinemia and lower extremity wounds |
| Q44131626 | Hyperhomocysteinemia and the MTHFR C677T mutation in Budd-Chiari syndrome |
| Q73103172 | Hyperhomocysteinemia and thrombosis |
| Q77621762 | Hyperhomocysteinemia and thrombosis |
| Q37033790 | Hyperhomocysteinemia and vascular access thrombosis in hemodialysis patients: a retrospective study |
| Q40425156 | Hyperhomocysteinemia and venous thrombosis |
| Q51550255 | Hyperhomocysteinemia in Greek patients with inflammatory bowel disease. |
| Q30802266 | Hyperhomocysteinemia: an independent risk factor or a simple marker of vascular disease? 2. Epidemiological data |
| Q46837706 | Impact of thrombophilic genetic factors on pulmonary embolism: early onset and recurrent incidences. |
| Q34249956 | Impaired homocysteine metabolism and atherothrombotic disease |
| Q47796229 | Incidence of arteriovenous thrombosis and the role of anticardiolipin antibodies in hemodialysis patients |
| Q57611907 | Influence of three potential genetic risk factors for thrombosis in 43 families carrying the factor V Arg 506 to Gln mutation |
| Q73401703 | Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis |
| Q40836256 | Long-term prognostic significance of homocysteine in middle-aged and elderly |
| Q73931084 | Low serum folate but normal homocysteine levels in patients with atherosclerotic vascular disease and matched healthy controls |
| Q51569081 | Methionine loading test is necessary for detection of hyperhomocysteinemia. |
| Q51482965 | Methionine-loading and random homocysteine tests have no added value in risk assessment for venous and arterial thrombosis. |
| Q43678276 | Mutations in the genes regulating methylene tetrahydrofolate reductase (MTHFR C-->T677) and cystathione beta-synthase (CBS G-->A919, CBS T-->c833) are not associated with myocardial infarction in African Americans |
| Q51561691 | Normohomocysteinaemia and vitamin-treated hyperhomocysteinaemia are associated with similar risks of cardiovascular events in patients with premature peripheral arterial occlusive disease. A prospective cohort study. |
| Q34706578 | Postmethionine-load homocysteine determination for the diagnosis hyperhomocysteinaemia and efficacy of homocysteine lowering treatment regimens |
| Q33893354 | Premature atherosclerosis in systemic lupus erythematosus |
| Q78167246 | Prevalence of mild hyperhomocysteinaemia and association with thrombophilic genotypes (factor V Leiden and prothrombin G20210A) in Italian patients with venous thromboembolic disease |
| Q41736603 | Pulmonary thrombosis, homocysteinemia, and reperfusion edema in an adolescent |
| Q36743749 | Recent advances in the treatment of thromboembolic diseases: venous thromboembolism |
| Q46346119 | Should plasma homocysteine be used as a biomarker of venous thromboembolism? A case-control study |
| Q33662944 | Stroke in childhood. |
| Q51500234 | The prevalence of thrombophilia in patients with symptomatic peripheral vascular disease. |
| Q73485462 | The prevalence of two genetic traits related to venous thrombosis in whites and African-Americans |
| Q33785883 | Total homocysteine and cardiovascular disease |
| Q36751693 | Vasa vitae--keeping the channels open |
| Q36884447 | Venous thrombosis in the elderly |
| Q33597786 | Venous thrombosis: a multicausal disease |
| Q51569420 | [A young patient with multiple arterial occlusions] |
| Q78006813 | [Angiology update] |
| Q78724057 | [Cerebral-vein thrombosis: retrospective study of twenty seven cases] |
| Q73700805 | [Hereditary thrombophilia in venous thromboembolic disease] |
| Q77421017 | [Homocysteine, 5,10-methylenetetrahydrofolate reductase and deep venous thrombosis. Survey of 120 patients in internal medicine] |
| Q51556745 | [Lowering high levels of fasting total homocysteine with folic acid and vitamins B in patients with venous thromboembolism: relationship between response and the C677T methylenetetrahydrofolate reductase (MTHRF) genotype] |
| Q74353796 | [New causes of inherited thrombophilia] |
Search more.